利用SPIES進行膀胱尿路上皮腫瘤診斷及治療-臺北市立聯合醫院之初步經驗
薛又仁1,3,4,黃建榮1,賴昱維1,陳修聖1,4,邱逸淳2,4,邱文祥1,4
1臺北市立聯合醫院仁愛院區泌尿科
2臺北市立聯合醫院忠孝院區泌尿科
3臺北市立聯合醫院教學研究部
4國立陽明大學醫學院醫學系泌尿學科
The application of spies in the diagnosis and treatment of bladder urothelial carcinoma-the preliminary report in taipei city hospital
1,3,4Thomas Y. Hsueh, 1,4Andy C. Huang, 1Yu-Wei Lai, 1,4Shiou-Sheng Chen, 2,4Yi-Chun Chiu, 1,4Allen W. Chiu
1Division of Urology, Department of Surgery, Taipei city Hospital, Ren-Ai branch
2Division of Urology, Department of Surgery, Taipei city Hospital, zhongxiao branch
3Department of Education and Research, Taipei city Hospital
4Department of Urology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
Purpose: To report our preliminary experience regarding the application of SPICE technology in the diagnosis and treatment of bladder urothelial carcinoma.
Patients and methods: A prospective randomized trial will be conducted from January 2015 to May 2015. A total of 30 patients with bladder urothelial carcinoma will be enrolled into this study. All patients received standard cystoscopy followed by SPICE technology cystoscopy. The number of tumor was counted under direct vision by two experienced urologists. All patients received transurethral resection of bladder tumor. All patients received standard treatment protocol and followed every 3 months using standard cystoscopy.
Results: The number of tumor diagnosed under standard cystoscopy or SPICE technology cystoscopy will be compared in this study. The incidence of tumor recurrence and metastasis will be calculated in this study.
Conclusion: Cystoscopy empowered with SPICE technology will be a viable option to assist the diagnosis and treatment of bladder urothelial carcinoma.